Inhibikase Therapeutics shares owned by ACT Capital Management
Quarter-by-quarter ownership of Inhibikase Therapeutics shares owned by ACT Capital Management
from 13F filings
Historical chart of ACT Capital Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by ACT Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-09-30 | $853k | 938k | 0.91 |
| 2022-06-30 | $696k | 938k | 0.74 |
| 2022-03-31 | $1.6M | 1.1M | 1.48 |
| 2021-12-31 | $1.6M | 1.1M | 1.47 |
| 2021-09-30 | $1.9M | 1.0M | 1.90 |
| 2021-06-30 | $2.5M | 875k | 2.80 |